CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer

Br J Cancer. 2003 Aug 4;89(3):533-8. doi: 10.1038/sj.bjc.6601114.

Abstract

Infiltrating CD1a(+) dendritic cells (DCs) have been associated with increased survival in a number of human cancers. This study investigated DC infiltration within breast cancers and the association with survival. Classical established prognostic factors, of tumour size, lymph node status, histological grade, lympho-vascular invasion, the KI-67 (MIB-1) fraction and the Nottingham Prognostic Index (NPI) were also compared. A total of 48 breast cancer patients were followed from the time of surgery and CD1a density analysis for 5 years or until death. Our data set validated previous studies, which show a relationship between survival and the NPI (P<0.001), tumour size (P<0.01) and lymph node status (P<0.05). Although more patients were alive at the 5-year time point in the group with higher CD1a DC density than the lower CD1a DC group, this failed to reach statistical significance at the P=0.05 level. Analysis at 10 years postsurgery is required to investigate the association further.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD1 / analysis*
  • Breast Neoplasms / pathology*
  • Dendritic Cells / immunology*
  • Dendritic Cells / physiology*
  • Female
  • Humans
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Survival Analysis

Substances

  • Antigens, CD1
  • CD1a antigen